U.S. Appeals Court Invalidates J & J Patent on Remicade U.S. Appeals Court Invalidates J & J Patent on Remicade

A U.S. appeals court on Tuesday upheld a ruling that invalidated a crucial Johnson& Johnson patent on its blockbuster rheumatoid arthritis drug Remicade, limiting J&J ’ s ability to seek damages from Pfizer Inc over its launch of a lower-cost version of the drug.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news